Jefferies reiterated a Buy rating and $223.00 price target on Shire (NASDAQ: SHPG) as investment interest slows, in part, reflecting ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Adamis Pharmaceuticals (ADMP) Announces Completion of US Compounding AcquisitionApril 12, 2016 6:46 AM BTIG Remains Positive on Shire's (SHPG) Orphan Disease Treatment Pipeline; Baxalta Deal Still in MotionApril 12, 2016 6:45 AM Top 10 News for 4/4 - 4/8: Treasury Stomps-Out Pfizer, Allergan Deal; Tesla's Model 3 is En Fuego; Valeant Sees LifeApril 8, 2016 3:52 PM Synergy Pharma (SGYP) Said to be Exploring Sale - SourceApril 8, 2016 10:51 AM